13F

SNWV SANUWAVE HEALTH INC

2026Q1 · CUSIP 80303D305 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
61
Δ holders QoQ
+2
Breadth percentile
Top 53%
Whale holders
32
Δ whales
-2
Inst. holding value
$74M
New positions
16
Closed positions
14
Price momentum (1Q)
Put / Call
0/0

Breadth history (34 quarters)

2025Q1: Δ+19 · h=20 2025Q2: Δ+27 · h=47 2025Q3: Δ+11 · h=58 2025Q4: Δ+1 · h=59 2026Q1: Δ+2 · h=61 2025Q1: holders=20 2025Q2: holders=47 2025Q3: holders=58 2025Q4: holders=59 2026Q1: holders=61 -27 -13.5 +0 +13.5 +27 184265 25Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q2 Top 11% -14.1% -37.1%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
12.4
EPS (TTM)
$0.96
EPS YoY
Revenue (TTM)
$0.0B
Revenue YoY
+22.5%
Quarterly Revenue & EPS (4Y)
2022-06-30: $4M 2022-09-30: $4M 2022-12-31: $5M 2023-03-31: $4M 2023-06-30: $5M 2023-09-30: $5M 2023-12-31: $7M 2024-03-31: $6M 2024-06-30: $7M 2024-09-30: $9M 2024-12-31: $10M 2025-03-31: $9M 2025-06-30: $10M 2025-09-30: $11M 2025-12-31: $13M 2026-03-31: $10M 2025-03-31: EPS -0.72 2025-06-30: EPS -0.04 2025-09-30: EPS 0.39 2025-12-31: EPS 0.78 2026-03-31: EPS -0.17 0M 7M 13M $M -0.79 0.03 0.86 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 61 2025-12-31: PE 60.72026-03-31: PE 17.6 16 40 64 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)